BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2987362)

  • 1. The responses of normal and psoriatic skin to single and multiple topical applications of leukotriene B4.
    Wong E; Camp RD; Greaves MW
    J Invest Dermatol; 1985 May; 84(5):421-3. PubMed ID: 2987362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of intraepidermal microabscesses by topical application of leukotriene B4.
    Camp R; Jones RR; Brain S; Woollard P; Greaves M
    J Invest Dermatol; 1984 Feb; 82(2):202-4. PubMed ID: 6319504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukotriene B4 fails to induce penetration of polymorphonuclear leukocytes into psoriatic lesions.
    Lammers AM; van de Kerkhof PC
    Br J Dermatol; 1987 Nov; 117(5):541-4. PubMed ID: 2825753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of polymorphonuclear leukocytes to topical leukotriene B4 in healthy and psoriatic skin.
    Lammers AM; van de Kerkhof PC
    Br J Dermatol; 1987 Apr; 116(4):521-4. PubMed ID: 3034322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of psoriatic lesions to multiple applications of leukotriene B4 and 12-HETE.
    Norris PG; Schofield O; Dowd PM; Greaves MW
    Dermatologica; 1987; 174(5):219-23. PubMed ID: 3034690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukotriene B4-induced accumulation of polymorphonuclear leukocytes in psoriatic skin.
    van de Kerkhof PC; Lammers AM; Mier PD; Happle R
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():637-9. PubMed ID: 2823562
    [No Abstract]   [Full Text] [Related]  

  • 7. Cutaneous responses to 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE) and 5,12-dihydroxyeicosatetraenoic acid (leukotriene B4) in psoriasis and normal human skin.
    Dowd PM; Black AK; Woollard PW; Greaves MW
    Arch Dermatol Res; 1987; 279(7):427-34. PubMed ID: 2829751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate inhibits the leukotriene B4 induced intraepidermal accumulation of polymorphonuclear leukocytes.
    van de Kerkhof PC; Bauer FW; Maassen-de Grood RM
    Br J Dermatol; 1985 Sep; 113(3):251a-255a. PubMed ID: 2998429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of leukotriene B4-induced intraepidermal accumulation of polymorphonuclear leukocytes by methotrexate in psoriasis.
    Lammers AM; van de Kerkhof PC; Mier PD
    Br J Dermatol; 1987 May; 116(5):667-71. PubMed ID: 3036194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraepidermal accumulation of polymorphonuclear leukocytes in annular pustular psoriasis.
    van de Kerkhof PC; Lammers AM
    Dermatologica; 1988; 176(6):282-7. PubMed ID: 2841175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal hyperproliferation following the induction of microabscesses by leukotriene B4.
    Bauer FW; van de Kerkhof PC; Maassen-de Grood RM
    Br J Dermatol; 1986 Apr; 114(4):409-12. PubMed ID: 3008801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of the cellular response of the rat conjunctiva to topically applied leukotriene B4.
    Trocmé SD; Gilbert CM; Allansmith MR; Bloch KJ; Abelson MB
    Ophthalmic Res; 1989; 21(4):297-302. PubMed ID: 2555760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphonuclear leucocyte chemotaxis in response to leukotriene B4 in treated and untreated psoriatics.
    Green CM; Ferguson J; MacLeod TM; Millar BW; Raffle EJ
    Dermatologica; 1989; 178(1):20-2. PubMed ID: 2537239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etretinate modulates the leukotriene B4 induced intra-epidermal accumulation of polymorphonuclear leukocytes.
    Lammers AM; van de Kerkhof PC
    Br J Dermatol; 1987 Sep; 117(3):297-300. PubMed ID: 2823858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The perivascular cell populations in human skin after topical application of leukotriene B4.
    Winkelmann RK; Camp R; English JS; Greaves MW
    Acta Derm Venereol; 1986; 66(4):340-3. PubMed ID: 2430407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eicosanoids in acute and chronic psoriatic lesions: leukotriene B4, but not 12-hydroxy-eicosatetraenoic acid, is present in biologically active amounts in acute guttate lesions.
    Fogh K; Herlin T; Kragballe K
    J Invest Dermatol; 1989 Jun; 92(6):837-41. PubMed ID: 2542417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged microvascular vasodilation induced by leukotriene B4 in human skin is cyclooxygenase independent.
    Larkin SW; Fraser L; Showell HJ; Williams TJ; Warren JB
    J Pharmacol Exp Ther; 1995 Jan; 272(1):392-8. PubMed ID: 7815355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dynamics of the response of normal skin to single and multiple epicutaneous leukotriene B4 applications analysed by three-colour flow cytometry.
    Glade CP; Botermans RJ; van Erp PE; van de Kerkhof PC
    Acta Derm Venereol; 1995 Nov; 75(6):437-41. PubMed ID: 8651019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ultrastructural study of transcutaneous migration of polymorphonuclear leukocytes following application of leukotriene B4.
    Paulissen M; Peereboom-Stegeman JH; van de Kerkhof PC
    Skin Pharmacol; 1990; 3(4):236-47. PubMed ID: 1964566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regulation of CD11b integrin levels on human blood leukocytes and leukotriene B4-stimulated skin by a specific leukotriene B4 receptor antagonist (LY293111).
    van Pelt JP; de Jong EM; van Erp PE; Mitchell MI; Marder P; Spaethe SM; van Hooijdonk CA; Kuijpers AL; van de Kerkhof PC
    Biochem Pharmacol; 1997 Apr; 53(7):1005-12. PubMed ID: 9174114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.